![](https://immunomart.com/wp-content/uploads/2024/05/HY-18938.gif)
Download Files:
Selonsertib
SKU
HY-18938-10 mg
Category Reference compound
Tags Apoptosis;MAP3K, Apoptosis;MAPK/ERK Pathway, Cancer
$92 – $704
Products Details
Product Description
– Selonsertib (GS-4997), an orally bioavailable, selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8.3, has been evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis.
Web ID
– HY-18938
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C24H24FN7O
References
– [1]Lin JH, et al. Design of a phase 2 clinical trial of an ASK1 inhibitor, GS-4997, in patients with diabetic kidney disease. Nephron. 2015;129(1):29-33.|[2]Lanier M, et al. Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure. ACS Med Chem Lett. 2017 Feb 8;8(3):316-320.|[3]Loomba R, et al. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2trial. Hepatology. 2018 Feb;67(2):549-559.
CAS Number
– 1448428-04-3
Molecular Weight
– 445.49
Compound Purity
– 98.99
SMILES
– O=C(NC1=NC(C2=NN=CN2C(C)C)=CC=C1)C3=CC(N4C=C(C5CC5)N=C4)=C(C)C=C3F
Clinical Information
– Phase 2
Research Area
– Cancer
Solubility
– DMSO : ≥ 31 mg/mL
Target
– Apoptosis;MAP3K
Isoform
– MAP3K5/ASK1
Pathway
– Apoptosis;MAPK/ERK Pathway
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.